Geode Capital Management, LLC Neuro Sense Therapeutics Ltd. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Geode Capital Management, LLC holds 11,963 shares of NRSN stock, worth $15,551. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,963
Previous 11,963
-0.0%
Holding current value
$15,551
Previous $13,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NRSN
# of Institutions
8Shares Held
225KCall Options Held
0Put Options Held
0-
Cantor Fitzgerald, L. P. New York, NY79.5KShares$103,3390.01% of portfolio
-
Xtx Topco LTD London, X046KShares$59,7940.0% of portfolio
-
Meitav Dash Investments LTD40KShares$52,0000.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il34.3KShares$44,5640.0% of portfolio
-
Commonwealth Equity Services, LLC12.6KShares$16,4120.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $15.2M